Exploratory study of biomarkers for therapeutic efficacy and immune-related adverse events of immune checkpoint inhibitors
Not Applicable
Recruiting
- Conditions
- All cancer types indicated for immune checkpoint inhibitor
- Registration Number
- JPRN-UMIN000043798
- Lead Sponsor
- Kumamoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Inclusion Criteria
Not provided
Exclusion Criteria
The patient whom the researcher consider to be inappropriate for the study.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Identification of genetic factors associated with immune-related adverse events
- Secondary Outcome Measures
Name Time Method Identification of genetic factors associated with the therapeutic effects of immune checkpoint inhibitors